Products & ReviewLife Sciences
dR-GalNAc (Alpha) CPG
CPG for incorporation of GalNAc at 3' end of an oligonucleotide, with a dR spacer.
Key features:
- Modification to enhance cell delivery of an oligonucleotide (such as siRNAs, ASOs, saRNAs, and anti-microRNAs)
- Used to add N-acetylgalactosamine (GalNAc) residue to the 3' end of an oligonucleotide
- dR functionality conforms to natural sugar-phosphate backbone
- Alpha anomer is nuclease resistant